191 related articles for article (PubMed ID: 21125155)
1. Anti-TNF therapy in renal amyloidosis in refractory rheumatoid arthritis: a new therapeutic perspective.
Nobre CA; Callado MR; Rodrigues CE; de Menezes DB; Vieira WP
Rev Bras Reumatol; 2010; 50(2):205-10. PubMed ID: 21125155
[TBL] [Abstract][Full Text] [Related]
2. Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis.
Smith GR; Tymms KE; Falk M
Intern Med J; 2004; 34(9-10):570-2. PubMed ID: 15482271
[TBL] [Abstract][Full Text] [Related]
3. Effective anti-TNF-alpha therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis.
Kuroda T; Wada Y; Kobayashi D; Murakami S; Sakai T; Hirose S; Tanabe N; Saeki T; Nakano M; Narita I
J Rheumatol; 2009 Nov; 36(11):2409-15. PubMed ID: 19797512
[TBL] [Abstract][Full Text] [Related]
4. [Use of etanercept in amyloidosis secondary to rheumatoid arthritis, a report of two cases].
Macías Fernández I; Fernández Rodríguez AM; García Pérez S
Reumatol Clin; 2011; 7(6):397-400. PubMed ID: 22078699
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
Nakamura T; Higashi S; Tomoda K; Tsukano M; Shono M
Rheumatology (Oxford); 2012 Nov; 51(11):2064-9. PubMed ID: 22879465
[TBL] [Abstract][Full Text] [Related]
6. The effect of etanercept on a case of amyloidosis secondary to ankylosing spondylitis: results of 2-year follow-up.
Yilmaz H; Kocabas H; Erkin G
Acta Reumatol Port; 2013; 38(4):299-301. PubMed ID: 24435036
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis.
Nakamura T; Higashi S; Tomoda K; Tsukano M; Baba S
Clin Exp Rheumatol; 2007; 25(4):518-22. PubMed ID: 17888205
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy.
Gottenberg JE; Merle-Vincent F; Bentaberry F; Allanore Y; Berenbaum F; Fautrel B; Combe B; Durbach A; Sibilia J; Dougados M; Mariette X
Arthritis Rheum; 2003 Jul; 48(7):2019-24. PubMed ID: 12847696
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
[TBL] [Abstract][Full Text] [Related]
10. Case report: Response in proteinuria due to AA amyloidosis but not Felty's syndrome in a patient with rheumatoid arthritis treated with TNF-alpha blockade.
Ravindran J; Shenker N; Bhalla AK; Lachmann H; Hawkins P
Rheumatology (Oxford); 2004 May; 43(5):669-72. PubMed ID: 15103032
[No Abstract] [Full Text] [Related]
11. No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy.
Simsek I; Kaya A; Erdem H; Pay S; Yenicesu M; Dinc A
J Nephrol; 2010; 23(1):119-23. PubMed ID: 20091495
[TBL] [Abstract][Full Text] [Related]
12. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.
Fernández-Nebro A; Tomero E; Ortiz-Santamaría V; Castro MC; Olivé A; de Haro M; Portales RG; González-Mari MV; Laffón A; García-Vicuña R
Am J Med; 2005 May; 118(5):552-6. PubMed ID: 15866260
[No Abstract] [Full Text] [Related]
13. [Beneficial effect of salazosulfapyridine (SASP) in a patient with secondary renal amyloidosis].
Hidaka M; Ohsawa I; Endo M; Fujita T; Ohi H; Kanmatsuse K; Kusumi Y; Yamaguchi Y
Nihon Jinzo Gakkai Shi; 1998 Sep; 40(7):555-9. PubMed ID: 9805922
[TBL] [Abstract][Full Text] [Related]
14. Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis.
Nakamura T
Mod Rheumatol; 2008; 18(2):109-18. PubMed ID: 18369528
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
[TBL] [Abstract][Full Text] [Related]
16. [Treatment with chlorambucil of renal amyloidosis secondary to rheumatoid arthritis. Study of 6 cases].
Robles NR; Roncero F; Arrobas M; Alvarez Vega JL; Sánchez Casado E
Med Clin (Barc); 1999 Oct; 113(12):456-8. PubMed ID: 10570514
[TBL] [Abstract][Full Text] [Related]
17. [Secondary amyloidosis in rheumatoid arthritis. A clinical study of 29 patients].
Fiter Aresté J; Nolla Solé JM; Gómez Vaquero C; Valverde García J; Roig Escofet D
An Med Interna; 1999 Dec; 16(12):615-9. PubMed ID: 10686712
[TBL] [Abstract][Full Text] [Related]
18. [Secondary amyloidosis associated with rheumatoid arthritis (RA)].
Koseki Y; Goto M
Nihon Rinsho; 2005 Jan; 63 Suppl 1():278-82. PubMed ID: 15799361
[No Abstract] [Full Text] [Related]
19. Combined treatment with cyclophosphamide and prednisolone can induce remission of nephrotic syndrome in a patient with renal amyloidosis, associated with rheumatoid arthritis.
Maezawa A; Hiromura K; Mitsuhashi H; Tsukada Y; Kanai H; Yano S; Naruse T
Clin Nephrol; 1994 Jul; 42(1):30-2. PubMed ID: 7923963
[TBL] [Abstract][Full Text] [Related]
20. [Methotrexate treatment of amyloidosis secondary to rheumatoid arthritis].
Fiter J; Nolla JM; Valverde J; Roig Escofet D
Rev Clin Esp; 1995 Jun; 195(6):390-2. PubMed ID: 7644787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
